Trial intelligence / Profile preview

MDMA-Assisted Therapy for Postpartum People With Co-occurring OUD and PTSD

NCT05219175Phase 2Recruiting

Sponsor
The University of New Mexico
Start
Apr 2024
Primary completion
Apr 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of midomafetamine in post-traumatic stress disorder (PTSD), opioid use disorder (OUD), sponsored by The University of New Mexico. Started Apr 2024; status: recruiting.

02

Drugs

midomafetamine
03

Conditions

post-traumatic stress disorder (PTSD)opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT05219175.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05219175.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call